Patients with SSc were linked to an increased risk for hematological malignancies, specifically B-cell malignancies.
Telitacicept, a dual inhibitor of the cytokines B-lymphocyte stimulator and a proliferation-inducing ligand, showed efficacy ...
Refractory dry eye in patients with systemic comorbidities can be challenging to manage because the underlying condition or ...
Objectives The European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of systemic lupus erythematosus (SLE) and lupus nephritis provide important guidance for ...
Section deals with the comprehensive list of drugs approved by FDA in 2023. Drug information includes the drug name and indication of use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback